Anti-MICA + MICB antibody [6D4]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Mouse Recombinant Monoclonal MICA antibody. Suitable for Flow Cyt and reacts with Human samples. Cited in 4 publications.
View Alternative Names
PERB11.1, MICA, MHC class I polypeptide-related sequence A, MIC-A
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-MICA + MICB antibody [6D4] (AB54413)
Flow cytometric analysis of Jurkat (Human T cell leukemia T lymphocyte, Left) / HeLa (Human cervix adenocarcinoma epithelial cell, Right) cells labelling MICA + MICB with ab54413 at 1/1000 dilution (0.1μg) (Red) compared with a Mouse monoclonal IgG (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti mouse IgG (Alexa Fluor® 488, ab150113) at 1/2000 dilution was used as the secondary antibody.
Negative control : Jurkat.
Gated on viable cells.
Related conjugates and formulations (1)
-
Anti-MICA + MICB antibody [6D4] - BSA and Azide free
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MICA and MICB act in the activation of the immune system by modulating NK cells and CD8+ T cell activities. These proteins do not form part of a complex but operate independently to signal the presence of infected or transformed cells to the immune system. They often appear on the cell surface under stress such as during viral infections or cancerous transformations activating immune cells to target and destroy these abnormal cells.
Pathways
The MICA/MICB interaction with NKG2D is integral to the immune checkpoint pathway. This pathway plays a significant role in regulating the immune system’s response to aberrant cells. Additionally MICA and MICB activity is linked to the regulation of the cytokine IFN-γ promoting the recruitment and activation of immune effector cells. The roles of these proteins in these pathways underline their importance in maintaining immune homeostasis and responding to pathological challenges.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 26:297 PubMed37274476
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:65743-65758 PubMed29029468
2017
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 17:1253-1265 PubMed27834580
2016
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 12:24 PubMed22257486
2012
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com